Publications by authors named "David Putney"

Claim this Profile
E
Evaluation of a hybrid remote clinical pharmacy services model.
Alexis Hyman, Engie Attia, David Putney, Laura M Blackburn

Am J Health Syst Pharm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REcycle Soon-to-Expire Program (RESTEP): Sustainability efforts in hospital pharmacy.
Kalina Korzec, Laura Blackburn, Niaz Deyhim, Amanda Beck, Jeffrey Tang, David Putney

Am J Health Syst Pharm· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of statins on incidence of gastrointestinal bleeding events among patients with continuous-flow left ventricular assist devices.
Hala Halawi, Jesse E Harris, Duc T Nguyen, Edward A Graviss, David Putney

Int J Artif Organs· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single-Center, Retrospective Cohort Study Evaluating the Use of Probiotics for the Prevention of Hospital-Onset Infection in Hospitalized Patients Receiving Intravenous Antibiotics.
Punit Jitendra Shah, Hala Halawi, Jessica Kay, Adanma Akogun, Silvia Wise, David Putney

Hosp Pharm· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alteplase for the treatment of midline catheter occlusions: a retrospective, single-cohort descriptive study.
Elsie Rizk, Anh Thu Tran, Frank Soto, David R Putney, Amaris Fuentes

Br J Nurs· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemodynamic Effects of Dexmedetomidine in Adults With Reduced Ejection Fraction Heart Failure.
Tara L Ruder, Kevin R Donahue, A Carmine Colavecchia, David Putney, Mukhtar Al-Saadi

J Intensive Care Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Time to In-Hospital Venous Thromboembolism in Obese Patients.
B Tate Cutshall, Alexandra W Tatara, Navneet Upadhyay, Mobolaji Adeola, David Putney

J Pharm Pract· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the efficacy and safety of apixaban and rivaroxaban in cancer patients receiving concomitant active anti-neoplastic therapy at an outpatient cancer setting.
Darin Yassine, Erika N Brown, David Putney, Oyejoke Fasoranti

J Oncol Pharm Pract· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct oral anticoagulants versus aspirin for venous thromboembolism prophylaxis after orthopedic surgery.
Tianrui Yang, Michelle Murillo, Aisha Vadhariya, Allison Wilson, David Putney

Am J Health Syst Pharm· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-center, retrospective evaluation of safety and efficacy of direct oral anticoagulants versus low-molecular-weight heparin and vitamin K antagonist in patients with cancer.
Elizabeth R Pritchard, Jose R Murillo, David Putney, Eleanor C Hobaugh

J Oncol Pharm Pract· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to Occurrence Based on Risk Stratification of Hospital-Acquired Venous Thromboembolism: A Retrospective Observational Cohort Study.
Alexandra W Tatara, Melanie Ruegger, Mobolaji Adeola, David Putney

J Pharm Pract· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-hospital use of non-steroidal anti-inflammatory drugs in patients with heart failure in academic centers in the United States.
Paulino A Alvarez, Duc T Nguyen, Robert Schutt, Cecilia Ganduglia, Jerry D Estep, David Putney

Int J Risk Saf Med· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Antifactor Xa and Activated Partial Thromboplastin Time Monitoring for Heparin Dosing in Vascular Surgery Patients: A Single-Center Retrospective Study.
Elsie Rizk, Allison D Wilson, Michelle U Murillo, David R Putney

Ther Drug Monit· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discharge medication complexity and 30-day heart failure readmissions.
A Carmine Colavecchia, David R Putney, Michael L Johnson, Rajender R Aparasu

Res Social Adm Pharm· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of in-hospital nonsteroidal antiinflammatory drug exposure in patients with a primary diagnosis of heart failure.
Paulino A Alvarez, David Putney, Richard Ogunti, Mamta Puppala, Cecilia Ganduglia

Cardiovasc Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Severe hypercalcemia mimicking ST-segment elevation myocardial infarction.
Robert C Schutt, John Bibawy, Mina Elnemr, Amy L Lehnert, David Putney

Methodist Debakey Cardiovasc J· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation and Pharmacokinetics of Treatment Dose Enoxaparin in Hospitalized Patients With Morbid Obesity.
Nathaniel R Thompson-Moore, Matthew A Wanat, David R Putney, Phuong H Nguyen Liebl, Wayne L Chandler

Clin Appl Thromb Hemost· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of anti-Xa and activated partial thromboplastin time monitoring for heparin dosing in patients with cirrhosis.
Amaris Fuentes, Sherilyn Gordon-Burroughs, Jeffrey B Hall, David R Putney, Howard P Monsour

Ther Drug Monit· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low molecular weight heparin dosing and monitoring in solid organ transplant recipients.
Misbah A Moten, A Osama Gaber, David Putney, Samir J Patel

Clin Transplant· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of drug-induced torsade de pointes risk for hospitalized high-risk patients receiving QT-prolonging agents.
Carla G M Jardin, David Putney, Stephen Michaud

Ann Pharmacother· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New agents to prevent strokes in nonvalvular atrial fibrillation.
David Putney, Craig Pratt

Methodist Debakey Cardiovasc J· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative monitoring of argatroban using plasma-diluted thrombin time.
Matthew A Wanat, Sara R Hart, David Putney, Michael G Liebl, Wayne Chandler

Ann Pharmacother· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardioprotective medication use after renal transplantation.
Kyle L Dawson, Samir J Patel, David Putney, Wadi N Suki, A Osama Gaber

Clin Transplant· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of computerized dosing on eptifibatide-associated bleeding and mortality.
David R Putney, Neal S Kleiman, Robert E Fromm, John M Buergler

Am Heart J· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Methodist Hospital CCU: a Beacon unit of excellence.
Tricia Lewis, Beatrice Abanobi, Paula Alleman, Eva Ballinas, Brenda Botbyl, David Putney

Crit Care Nurs Clin North Am· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis